FDA Drug Application (021829) for NEUPRO by UCB INC

Back to FDA Applications sponsored by UCB INC

Application Number021829
Product Number001
FormFILM, EXTENDED RELEASE;TRANSDERMAL
Dosage2MG/24HR
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameNEUPRO
Active IngredientROTIGOTINE



Back to FDA Applications sponsored by UCB INC